A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder: A Retrospective Experience

BACKGROUND: Neoadjuvant cisplatin-based chemotherapy improves survival in muscle-invasive urothelial cancer, with MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) considered the standard regimen. Gemcitabine plus cisplatin (GC) has similar efficacy and less toxicity than MVAC in metastati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dash, Atreya, Pettus, Joseph A., Herr, Harry W., Bochner, Bernard H., Dalbagni, Guido, Donat, S. Machele, Russo, Paul, Boyle, Mary G., Milowsky, Matthew I., Bajorin, Dean F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2585515/
https://ncbi.nlm.nih.gov/pubmed/18823036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23848
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados